AMGEN INC (AMGN)       225.99  -0.88 (-0.39%)

225.99  -0.88 (-0.39%)

US0311621009 - Common Stock - Premarket: 228.97 +2.98 (+1.32%)

News Image
20 hours ago - InvestorPlace

Warning! A Housing Market Crash Will Tank These 3 Stocks.

Don't be complacent about a potential black-swan event. A housing market crash would send these three stocks plunging.

News Image
a day ago - InvestorPlace

The 7 Best Stocks to Buy to Tap Into a Hidden Bull Market

Despite the ongoing worries on Wall Street, these are the best stocks to buy to play the hidden bull market.

News Image
5 days ago - Investor's Business Daily

Ionis Pharmaceuticals Nosedives After AstraZeneca Drops High Cholesterol Drug Test

Though successful in early testing, it wasn't enough to win a Phase 3 study.

News Image
6 days ago - Market News Video

AMGN November 4th Options Begin Trading

News Image
9 days ago - Investor's Business Daily

Here Are 10 Biotech Stocks — Including Catalyst And Viridian — That Would Have Netted You $10,000 More This Year

The biotech run off a June bottom is great — until you realize you could've netted more.

News Image
9 days ago - Market News Video

Dow Movers: MRK, HD

News Image
13 days ago - Investor's Business Daily

Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin

The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.

News Image
16 days ago - BusinessInsider

AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., Sept. 12, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch's 2022 Global Healthcare C...

News Image
16 days ago - Amgen

AMGEN ANNOUNCES WEBCAST OF 2022 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Bank of America Merrill Lynch's 2022 Global Healthcare Conference at 4:55 a.m. ET on Thursday, Sept. 15,...

News Image
16 days ago - Market News Video

Nasdaq 100 Movers: AMGN, SPLK

News Image
16 days ago - Market News Video

Dow Movers: AMGN, MMM

News Image
16 days ago - InvestorPlace

Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment

Bristol-Myers Squibb is going after Amgen's $2 billion a year Otezla franchise with Sotyktu. BMY stock is up on the news.

News Image
16 days ago - Amgen

LUMAKRAS® (SOTORASIB) COMBINED WITH VECTIBIX® (PANITUMUMAB) SHOWS CONFIRMED 30% OBJECTIVE RESPONSE RATE IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced updated data from its Phase 1b CodeBreaK 101 study, one of the most comprehensive global clinical...

News Image
17 days ago - Amgen

LUMAKRAS®/LUMYKRAS® (SOTORASIB) DEMONSTRATES SUPERIOR PROGRESSION-FREE SURVIVAL OVER DOCETAXEL IN FIRST POSITIVE PHASE 3 TRIAL OF A KRAS G12C INHIBITOR IN NON-SMALL CELL LUNG CANCER

/PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced detailed results from the global Phase 3 CodeBreaK 200 trial, which showed once-daily oral...

News Image
20 days ago - BusinessInsider

AMGEN ANNOUNCES WEBCAST OF 2022 MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE

THOUSAND OAKS, Calif., Sept. 8, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 2022 Global Healthcare Conference at 9:1...

News Image
20 days ago - Amgen

AMGEN ANNOUNCES WEBCAST OF 2022 MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at Morgan Stanley's 2022 Global Healthcare Conference at 9:10 a.m. ET on Tuesday, Sept. 13, 2022. Robert A....

News Image
20 days ago - BusinessInsider

AMGEN ANNOUNCES POSITIVE NEW DATA AT EADV 2022 FOR OTEZLA® (APREMILAST)

SPROUT Data Show Otezla Resulted in Significant Improvements in Measures of Moderate to Severe Plaque Psoriasis at Week 16 Compared With Placebo i...

News Image
20 days ago - Amgen

AMGEN ANNOUNCES POSITIVE NEW DATA AT EADV 2022 FOR OTEZLA® (APREMILAST)

/PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced results from two significant Phase 3 clinical studies of oral Otezla® (apremilast), demonstrating efficacy...

News Image
21 days ago - BusinessInsider

AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2022

THOUSAND OAKS, Calif., Sept. 7, 2022 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with...

News Image
21 days ago - Amgen

AMGEN TO WEBCAST INVESTOR CALL AT ESMO 2022

/PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcast call for the investment community in conjunction with the European Society for Medical Oncology Annual...

News Image
22 days ago - InvestorPlace

7 Dow Stocks With Superior Fundamentals

Robust Dow stocks offer attractive deals for patient investors amidst an unstable economic environment

News Image
22 days ago - Market News Video

Dow Movers: WMT, CAT